220 related articles for article (PubMed ID: 11263847)
21. Trials of lipid-lowering therapy in secondary prevention of coronary heart disease.
Olsson AG; Pedersen T; Bergdahl B
Curr Opin Lipidol; 1995 Dec; 6(6):369-73. PubMed ID: 8750250
[TBL] [Abstract][Full Text] [Related]
22. Simvastatin therapy for hypercholesterolaemia in patients with coronary heart disease.
French JK; White HD; Greaves SC
N Z Med J; 1990 Feb; 103(883):41-3. PubMed ID: 2304688
[TBL] [Abstract][Full Text] [Related]
23. Noncholesterol sterols and cholesterol lowering by long-term simvastatin treatment in coronary patients: relation to basal serum cholestanol.
Miettinen TA; Strandberg TE; Gylling H
Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1340-6. PubMed ID: 10807752
[TBL] [Abstract][Full Text] [Related]
24. Low-fat formulations of plant stanols and sterols.
Salo P; Wester I
Am J Cardiol; 2005 Jul; 96(1A):51D-54D. PubMed ID: 15992517
[TBL] [Abstract][Full Text] [Related]
25. Cholesterol-lowering efficacy of a sitostanol-containing phytosterol mixture with a prudent diet in hyperlipidemic men.
Jones PJ; Ntanios FY; Raeini-Sarjaz M; Vanstone CA
Am J Clin Nutr; 1999 Jun; 69(6):1144-50. PubMed ID: 10357732
[TBL] [Abstract][Full Text] [Related]
26. Effects of phytosterol ester-enriched margarine on plasma lipoproteins in mild to moderate hypercholesterolemia are related to basal cholesterol and fat intake.
Mussner MJ; Parhofer KG; Von Bergmann K; Schwandt P; Broedl U; Otto C
Metabolism; 2002 Feb; 51(2):189-94. PubMed ID: 11833047
[TBL] [Abstract][Full Text] [Related]
27. Plant sterols as dietary adjuvants in the reduction of cardiovascular risk: theory and evidence.
Patch CS; Tapsell LC; Williams PG; Gordon M
Vasc Health Risk Manag; 2006; 2(2):157-62. PubMed ID: 17319460
[TBL] [Abstract][Full Text] [Related]
28. Cholesterol reduction by different plant stanol mixtures and with variable fat intake.
Gylling H; Miettinen TA
Metabolism; 1999 May; 48(5):575-80. PubMed ID: 10337856
[TBL] [Abstract][Full Text] [Related]
29. A healthy diet rich in carotenoids is effective in maintaining normal blood carotenoid levels during the daily use of plant sterol-enriched spreads.
Ntanios FY; Duchateau GS
Int J Vitam Nutr Res; 2002 Jan; 72(1):32-9. PubMed ID: 11887750
[TBL] [Abstract][Full Text] [Related]
30. Cholesterol-lowering effect of stanol ester in a US population of mildly hypercholesterolemic men and women: a randomized controlled trial.
Nguyen TT; Dale LC; von Bergmann K; Croghan IT
Mayo Clin Proc; 1999 Dec; 74(12):1198-206. PubMed ID: 10593347
[TBL] [Abstract][Full Text] [Related]
31. Non-adherence to lipid-lowering therapies: a need for more studies to evaluate reasons for medication non-adherence.
Wong MC; Wang HH; Liu KS
Int J Clin Pract; 2011 Dec; 65(12):1321-2. PubMed ID: 22093540
[No Abstract] [Full Text] [Related]
32. Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals.
Shepherd J; Hunninghake DB; Barter P; McKenney JM; Hutchinson HG
Am J Cardiol; 2003 Mar; 91(5A):11C-17C; discussion 17C-19C. PubMed ID: 12646338
[TBL] [Abstract][Full Text] [Related]
33. Effects of lipid-lowering therapy on total and coronary mortality.
Holme I
Curr Opin Lipidol; 1995 Dec; 6(6):374-8. PubMed ID: 8750251
[TBL] [Abstract][Full Text] [Related]
34. Influence of simvastatin, fenofibrate and/or ezetimibe on correlation of low-density lipoprotein and nonhigh-density lipoprotein cholesterol with apolipoprotein B in mixed dyslipidemic patients.
Farnier M; Taggart W; Dong Q; Lin J; Shah A; Brudi P
J Clin Lipidol; 2011; 5(3):179-187. PubMed ID: 21600523
[TBL] [Abstract][Full Text] [Related]
35. Predictors of change in low-density lipoprotein size during lipid-lowering treatment in type 2 diabetes.
Wägner AM; Ordóñez-Llanos J; Jorba O; Pérez A
Metabolism; 2004 Nov; 53(11):1516. PubMed ID: 15558848
[No Abstract] [Full Text] [Related]
36. Meta-analysis of natural therapies for hyperlipidemia: plant sterols and stanols versus policosanol.
Chen JT; Wesley R; Shamburek RD; Pucino F; Csako G
Pharmacotherapy; 2005 Feb; 25(2):171-83. PubMed ID: 15767233
[TBL] [Abstract][Full Text] [Related]
37. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
Evans M; Roberts A; Davies S; Rees A
Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
[TBL] [Abstract][Full Text] [Related]
38. [Overviews of fibrate].
Tada N
Nihon Rinsho; 2001 Mar; 59 Suppl 3():609-17. PubMed ID: 11347141
[No Abstract] [Full Text] [Related]
39. Improvement of cholesterol levels and reduction of cardiovascular risk via the consumption of phytosterols.
Ortega RM; Palencia A; López-Sobaler AM
Br J Nutr; 2006 Aug; 96 Suppl 1():S89-93. PubMed ID: 16923260
[TBL] [Abstract][Full Text] [Related]
40. Implications of 4S evidence on baseline lipid levels.
Durrington PN
Lancet; 1995 Jul; 346(8968):181. PubMed ID: 7661979
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
